Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 180

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 180
---

    Weighted- average
                                            exercise price
                                            of outstanding options, warrants and
                                            rights  
    Number
                                            of securities remaining available
                                            for future
                                            issuance under
                                            equity compensation plans
                                            (excluding securities reflected
                                            in column
                                            (a)) 

     (a)  
     (b)  
     (c) 

    Equity compensation
    plans approved by security holders 
     11,594,210  
    $0.45  
     3,900,000 
  
    Total 
     11,594,210  
    $0.45  
     3,900,000 

Item
6. Selected Financial Data

[Reserved].

Item
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Certain
statements contained in this Annual Report are “forward-looking statements” within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act, and are subject to the “safe harbor” created by these sections. Future filings with
the SEC, future press releases and future oral or written statements made by us or with our approval, which are not statements of historical
fact, may also contain forward-looking statements. Because such statements include risks and uncertainties, many of which are beyond
our control, actual results may differ materially from those expressed or implied by such forward-looking statements. Some of the factors
that could cause actual results to differ materially from those expressed or implied by such forward-looking statements can be found
under the caption “Risk Factors” in Part I, Item 1A, and elsewhere in this Annual Report. The forward-looking statements
speak only as of the date on which they are made, and we undertake no obligation to update such statements to reflect events that occur
or circumstances that exist after the date on which they are made.

The
following discussion should be read in conjunction with the financial statements and the accompanying notes for the periods ended December
31, 2024 and December 31, 2023 appearing elsewhere in this Annual Report. Our actual results could differ materially from those expressed
or implied in any forward-looking statements as a result of various factors, including those set forth under the caption “Risk
Factors” in Part I, Item 1A.

Items
Affecting Comparability of Financial Results

During
the year ended December 31, 2023, the Company purchased Collins Building, as described in